Familiar primary pulmonary hypertension

Authors

  • Célia Nascimento Assistente Hospitalar de Medicina Interna, Serviço de Medicina Interna e Serviço de Anatomia Patológica do Hospital de Santa Cruz
  • Ana Paula Martins Assistente Hospitalar Graduada e Directora do Serviço de Ana­tomia Patológica, Serviço de Medicina Interna e Serviço de Anatomia Patológica do Hospital de Santa Cruz
  • Sância Ramos Assistente Hospitalar de Anatomia Patológica, Serviço de Anatomia Patológica do Hospital de Santa Cruz
  • Octávio Ribeiro Chefe de Serviço de Medicina Interna, Serviço de Medicina Interna e Serviço de Anatomia Patológica do Hospital de Santa Cruz
  • Maria João Pais Directora do Serviço de Medicina Interna, Serviço de Medicina Interna do Hospital de Santa Cruz

Keywords:

primary pulmonary hypertension

Abstract

Primary pulmonary hypertension is a rare disease and may present in as an autosomal dominant pattern with incomplete penetrance .

We describe two cases of primary pulmonary hypertension, which developed in two brothers aged 27 and 33 years, born of a consanguineous marriage, but whose parents showed no evidence of pulmonary hypertension.

Both patients presented with dyspnea on exertion with a rapidly fatal outcome, despite aggressive medical therapy.

Grade V (angiomatoid lesions) and grade III (concentric intimai fibrosis) lesions were documented respectively at the autopsy and in the premorbid pulmonary biopsy of each patient.

Downloads

Download data is not yet available.

References

Fuster V, Steele P et ai. Pathophysiology and Natural History Pulmonary Hypertension Primary pulmonary hypertension: natural history a I nd the importance of thrombosis. Circulation 1984; 70 (4) 580-587.

Barst R, Loyd J. Genetics and lmmunogenetic Aspects of Primary Pulmonary Hypertension. Chest1998;114(3): 231S - 236S.

Prichard JS. Pulmonary Hypertension, Oxford Textbook of Medicine DJ Weatherall, JGG. Ledingham and DA Warrell, Oxford University Press 1996: 2505 - 2514.

Loyd JE, PrimmRK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respiratory Diseases 1984; 129( 1): 194 - 197.

Loyd JE, Atkinson JB, Pietra GG et ai. Heterogeneity of pathologic lesions in familial primary pulmonary hypertension. Am Rev Respiratory Diseases 1988; 138(4): 952 - 957.

Giaid A, Saleh D. Reduced Expression of Endothelial Nitric Oxide Synthase in the Lungs of Patients with Pulmonary Hypertension. N Engl J Med 1995; 27: 214 - 222.

Giaid A, Yanagisawa M et ai. Expression of Endothelin-1 in lhe Lungs of Patients with Pulmonary Hypertension. N Engl J Med 1993;17:1732 - 1739.

Katzenstein ALA, Askin FB. Pulmonary Hypertension and other Vascular Disorders Surgical Pathology of Non - Neoplastic Lung Disease Second Edition 1990: 432 - 467.

lnbar S, Schrader BJ, Kaufmann E et ai. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension. J AM Coll Cardiology 1993; 21(2): 413- 418.

Schrader BJ. Pharmd, Shmuel lnbar et al. Comparation of The Effects of Adenosine and Nifedipi9e in lhe Pulmonary Hypertension. JACC 1992; 19(5): 1060-1064.

Chapelier A, Macchiarini P, Cerrina J et al. Comparative Outcome of Heart-Lung and Lung Transplantation for Pulmonary Hypertension. J Thoracic and Cardiov Surgery 1993; 106(2): 299-307.

Additional Files

Published

1999-06-30

How to Cite

1.
Nascimento C, Martins AP, Ramos S, Ribeiro O, Pais MJ. Familiar primary pulmonary hypertension. RPMI [Internet]. 1999 Jun. 30 [cited 2024 Dec. 18];6(2):111-4. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/2053

Issue

Section

Case Reports

Similar Articles

You may also start an advanced similarity search for this article.